
|Articles|October 1, 2001
Four-drug regimen improves IC pain and QoL scores
Dublin, Ireland-A dimethyl sulfoxide (DMSO) "cocktail" significantly improves pain and quality-of-life scores in interstitial cystitis patients, and the regimen may serve as an alternative to other instillation treatments in patients whose principal complaint is pain rather than frequency and urgency, according to researchers from Gartnavel General Hospital, Glasgow, Scotland.
Advertisement
Advertisement
Related Content
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves capivasertib plus abiraterone and prednisone for PTEN-deficient mHSPC
2
Toni Choueiri, MD, reacts to FDA approval of adjuvant belzutifan with pembrolizumab for ccRCC
3
Dean Elterman, MD, highlights efficacy and safety data on the Zenflow Prostatic Spring
4
FDA approves adjuvant belzutifan with pembrolizumab for ccRCC
5










